Advertisement
Advertisement
Skip to content
Follow Us on
Advertisement
TOP STORIES
Finance

New India Vatsalya Health Policy: Surrogate Mother and Oocyte Donor Cover, Claims, GST and Tax

Summary: New India Vatsalya Health Policy (UIN NIAHLIP25061V012425) is a specialised individual indemnity policy for medical complications suffered by a surrogate mother or an oocyte donor in a legally compliant altruistic-surrogacy or assisted-reproductive-technology arrangement. Option I provides a three-year policy with a ₹5 lakh sum insured for the surrogate mother; Option II provides a one-year policy with a ₹2 lakh sum insured for the oocyte donor. It is available only where the intending woman or commissioning couple holds one of the insurer’s specified base health policies. This guide explains eligibility, the narrow insured event, room and AYUSH limits, the 30-day initial waiting period, exclusions, cashless and reimbursement claims, grievance escalation, GST treatment and the conditional income-tax deduction. It is not a general maternity policy and does not insure the child, the intended parents or the surrogacy procedure itself.

Advertisement

Vatsalya’s verified identity and unusually narrow insured purpose

The New India Assurance Company Limited is the insurer. Its current product page and prospectus identify the product as New India Vatsalya Health Policy (Cover for Surrogate Mother and Oocyte Donor), UIN NIAHLIP25061V012425. The UIN should be matched on the proposal, customer information sheet, schedule and issued wording. This is not a broad maternity, fertility or family health plan. It is an indemnity contract designed for specified medical complications of one named surrogate mother or one named oocyte donor in an arrangement that satisfies Indian surrogacy and assisted-reproductive-technology law.

The policyholder and the insured person may not be the same. The intending woman or commissioning couple must hold one of the insurer’s specified base health policies, while the person medically covered under Vatsalya is the surrogate mother or oocyte donor named in the schedule. The official prospectus lists New India Mediclaim Policy, New India Floater Mediclaim Policy, New India Premier Mediclaim Policy and Yuva Bharat Health Policy as qualifying base products. Merely holding another New India policy, or producing a clinic agreement, does not satisfy that condition unless the current insurer documents accept it.

Contract element Option I: surrogate mother Option II: oocyte donor
Covered event Pregnancy and postpartum complications within policy terms Complications arising from oocyte retrieval within policy terms
Policy duration Three years One year
Sum insured ₹5 lakh, individual basis ₹2 lakh, individual basis
Persons covered One named surrogate mother One named oocyte donor
Key legal setting Compliant altruistic surrogacy; statutory eligibility must be met Compliant oocyte donation under applicable ART requirements

Who can arrange the cover and what must exist before inception

The product connects insurance underwriting with a regulated reproductive arrangement. The proposal form asks for the identities and relevant documentation of the intending woman or couple and the proposed insured. It also requires medical and procedural information. The insurer may request statutory certificates, clinic documents, consent records, health records and evidence of the qualifying base policy. Acceptance is not automatic. A clinic’s willingness to proceed, a physician’s certificate or a surrogacy agreement does not bind the insurer unless the risk is accepted and the schedule is issued.

The surrogate mother cannot supply her own gamete

The official materials exclude an arrangement in which the surrogate mother uses her own gametes. They also exclude a second surrogacy and commercial rather than altruistic surrogacy. These are not minor administrative conditions: they reflect the legal architecture governing permissible surrogacy in India. If the arrangement is outside applicable law, the policy cannot be treated as a fallback source of financing. The parties should obtain specialist legal and medical advice before proposal and disclose the entire arrangement accurately.

One insured person and one defined episode

The cover is issued for one surrogate mother or one oocyte donor, not as a family floater. The sum insured is therefore personal to the named insured and cannot be transferred to another donor or substitute surrogate. If the reproductive arrangement changes before treatment, the policyholder should obtain written confirmation from the insurer rather than assuming an endorsement is available. The policy period and insured event should align with the medical timeline, but the insurer’s accepted dates—not informal treatment estimates—control.

Expenses Vatsalya can pay and the limits attached to hospital care

The core benefit is hospitalisation for an admissible complication connected with the insured event. The prospectus describes room, boarding and nursing; medical practitioners’ fees; anaesthesia, blood, oxygen and operation-theatre charges; medicines and diagnostics; and other necessary inpatient expenses, subject to definitions and exclusions. The expense must be medically necessary, reasonable and customary, and incurred in India during the operative policy period. A complication is not established simply because treatment follows a pregnancy or oocyte retrieval; the medical records must demonstrate the causal and contractual link.

Room entitlement and proportionate deduction

The stated room entitlement is a single air-conditioned room costing no more than ₹8,000 per day. Intensive-care expenses are payable at actuals, subject to the remaining sum insured and other terms. If the insured occupies a room above entitlement, the policy applies proportionate deduction to associated expenses. The prospectus identifies exceptions, including pharmacy and consumables, implants and medical devices, diagnostics, ICU charges and hospitals that do not vary associated charges by room category. A planned admission should therefore include written confirmation of eligible room category and an itemised estimate.

AYUSH hospitalisation for an otherwise covered complication is included up to the single-private-room category described in the documents and must occur in an eligible AYUSH hospital or facility. This is not permission to claim wellness services, outpatient therapies or any treatment unrelated to the insured event. Medical necessity, prescribed records and facility eligibility remain essential. The sum insured is one ceiling across admissible benefits; AYUSH does not create an additional pool.

Benefit or control Verified document position Claim consequence
Initial waiting period 30 days for the covered event Treatment during the waiting period is generally outside cover, subject to exact wording.
Room rent Single AC room, maximum ₹8,000 per day Higher room selection can trigger proportionate deduction.
ICU Actuals Still subject to medical necessity, exclusions and available sum insured.
AYUSH Covered for the insured event in an eligible facility Not a general wellness or unrelated-treatment benefit.
Geography Treatment in India Overseas treatment is excluded.
Settlement Cashless at eligible network facility or reimbursement Both routes require admissibility and complete evidence.

The exclusions that separate complication cover from fertility financing

Vatsalya does not pay the ordinary cost of the surrogacy or assisted-reproduction procedure. Delivery expenses, treatment of the foetus or newborn, outpatient care and the underlying reproductive procedure are excluded. The contract also excludes pre-existing diseases or conditions and treatment outside India. The presence of a medically complex pregnancy does not expand the benefit into general obstetric cover. Every bill must be classified by the treating hospital so that expenses for a covered complication are not mixed with excluded procedure, delivery or newborn charges.

Legal compliance is a coverage issue. Commercial surrogacy, non-altruistic arrangements, a second surrogacy, use of the surrogate’s own gametes and non-compliance with the Surrogacy or ART framework are among the stated exclusions. Misrepresentation or omission in the proposal can independently affect the claim. Parties should resist generic package invoices: the insurer needs diagnoses, procedures, dates and itemised expenses to distinguish the insured complication from excluded reproductive services.

  • Do not treat the ₹5 lakh or ₹2 lakh sum insured as a guaranteed payment; it is the maximum pool for admissible expenses.
  • The child, foetus, intended parents and procedure costs are not automatically insured merely because a Vatsalya policy exists.
  • Pre-existing medical conditions and unrelated admissions require close clause review and may fall outside cover.
  • The legal validity of the reproductive arrangement should be established before proposal, not after a claim arises.

Cashless, reimbursement and the documentary chain for a sensitive claim

For cashless treatment, the insured should use a current network hospital and have the hospital send a pre-authorisation request to the insurer or its authorised TPA. The request should identify the covered complication and separate excluded costs. The insurer may approve, query or decline cashless access. A cashless denial does not necessarily mean that a reimbursement claim is finally rejected, but it does require the patient or policyholder to fund treatment and later establish admissibility. Emergency care should not be delayed solely to obtain administrative approval.

Records that should be preserved

The file should include the issued schedule, base-policy evidence, statutory eligibility documents, proposal disclosures, pre-authorisation correspondence, treating-doctor notes, operative or procedure notes, discharge summary, investigation reports, prescriptions, itemised bills, payment receipts and bank details. Where charges relate partly to the reproductive procedure and partly to a complication, the hospital should allocate them explicitly. The prospectus requires post-hospitalisation documents to be submitted within 15 days after completion of treatment; the exact applicable timeline and any condonation process should be checked in the issued wording.

Grievance escalation without losing the evidence trail

A deduction or rejection should be requested in writing with the clause and calculation. The first escalation is the insurer’s grievance mechanism, using the current contact details and preserving the reference number. If unresolved, the complainant can use IRDAI’s Bima Bharosa grievance platform and may approach the Insurance Ombudsman where the complaint falls within its jurisdiction. These channels do not replace urgent medical decisions, statutory surrogacy compliance or independent legal remedies.

Premium, GST position and the limited role of Section 80D

Premium is determined by the insurer’s filed rates, option, insured person’s medical information and underwriting. A public article cannot state a valid personalised premium. From 22 September 2025, services of individual health insurance, including family-floater policies, were exempted from GST under the notified change. Vatsalya is documented as an individual health policy, but the proposer should still inspect the invoice, transaction date and issued contract. The exemption does not rewrite coverage or make any clinic fee or excluded procedure tax-free.

Section 80D of the Income-tax Act can permit a deduction for eligible health-insurance premium, within the statutory blocks and limits, when the taxpayer, insured relationship, payment method and chosen tax regime satisfy the law. The individual limits are generally ₹25,000 for self, spouse and dependent children and a separate ₹25,000 for parents, rising to ₹50,000 for the relevant block where the insured is a senior citizen. Vatsalya presents an unusual relationship structure: the named insured may be a surrogate mother or donor rather than the taxpayer or an eligible relative. A payer should not assume deductibility merely because the contract is health insurance. The default new tax regime also generally restricts Section 80D. Obtain fact-specific tax advice and retain the premium certificate and payment evidence.

Frequently Asked Questions on New India Vatsalya Health Policy

Is Vatsalya a maternity policy for the intending couple?

No. It is a narrow indemnity policy for specified complications suffered by the named surrogate mother or oocyte donor. It does not provide general maternity benefits to the intending woman or couple.

Does the ₹5 lakh surrogate-mother option pay for delivery and the newborn?

No. The ordinary delivery expense and treatment of the foetus or newborn are excluded. The sum insured responds only to admissible complications under the wording.

Can the policy be purchased without another New India health policy?

The current prospectus makes availability conditional on the intending woman or commissioning couple holding one of the specified New India base health policies.

Can a different donor use the same policy if the original donor changes?

The policy covers the named insured person. A change should never be assumed; obtain the insurer’s written decision and any valid endorsement before treatment.

Does choosing a room above ₹8,000 affect only the room charge?

Not necessarily. Proportionate deduction can apply to associated charges, subject to the listed exceptions and the hospital’s billing model.

Does cashless refusal mean the medical claim is finally rejected?

No. Cashless is a settlement facility. Reimbursement may still be examined if the expense is otherwise admissible and fully documented, although the patient may need to fund treatment first.

Is the premium automatically deductible under Section 80D?

No. The payer, relationship to the insured, payment mode, statutory limit and tax regime all matter. The special policyholder-insured relationship makes individual tax advice important.

Key Takeaways

  • Match UIN NIAHLIP25061V012425 on every issued document and confirm the qualifying base policy.
  • Option I is three-year ₹5 lakh cover for one surrogate mother; Option II is one-year ₹2 lakh cover for one oocyte donor.
  • The policy covers defined complications, not the reproductive procedure, ordinary delivery, foetus, newborn or intended parents.
  • Room entitlement, the 30-day waiting period, exclusions, legal compliance and itemised evidence can materially affect a claim.
  • GST exemption and Section 80D are separate questions; tax deductibility is not automatic in this unusual relationship structure.

*****

Disclaimer: This article is a current-date educational explanation of New India Vatsalya Health Policy (Cover for Surrogate Mother and Oocyte Donor) and is not insurance, medical, fertility, surrogacy, tax or legal advice; an offer, solicitation, endorsement, comparison or recommendation; or a statement that any person or arrangement is eligible. Product availability, UIN status, premium rates, underwriting, base-policy requirements, network hospitals, claims procedures, tax rules and the Surrogacy and Assisted Reproductive Technology framework can change after 30 October 2026. Cover exists only for the named person accepted by The New India Assurance Company Limited and recorded in the issued schedule, subject to the proposal, declarations, policy wording, customer information sheet, endorsements, statutory eligibility, waiting period, exclusions, room entitlement, proportionate deductions, medical necessity, reasonable-and-customary limits, available sum insured and complete claim evidence. The policy is not general maternity or fertility financing: procedure costs, ordinary delivery, the foetus or newborn, intended parents and unrelated or non-compliant treatment may be outside cover. Cashless authorisation is not a promise of complete payment, and denial of cashless access is not necessarily final rejection of a properly documented reimbursement claim. Readers must obtain the latest official documents and a personalised written decision from the insurer, make complete medical and legal disclosures, confirm the validity of the reproductive arrangement with appropriately qualified professionals, and seek independent advice from a doctor, lawyer, chartered accountant and IRDAI-licensed insurance intermediary for their facts. GST treatment depends on the transaction and contract; Section 80D depends on the payer, insured relationship, payment mode, limits and tax regime and must not be assumed. TaxGuru accepts no responsibility for any loss, expense, denial, treatment outcome, coverage gap, tax position, legal consequence or decision arising from reliance on this article, incomplete facts, insurer interpretation, clinical events or later changes in law or official documents.

Advertisement

Author Info

CA Sandeep Kanoi
Qualification: Graduate, CA in Job / Business, DD
Company: Taxguru Consultancy
Location: Mumbai, Maharashtra
Articles Published: 23,202

Join TaxGuru's Network for the latest updates on Income Tax, GST, Company Law, Corporate Laws and other related subjects.

Leave a Reply

Your email address will not be published. Required fields are marked *